Proglumide

Known as: Xilamide, Proglumide [Chemical/Ingredient], 242 DL 
A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
FREE Full Text 6. ↵ Andrews G (2001) Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry 178: 192… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1997
Highly Cited
1997
In patients who reported mild postoperative pain, we evoked a nocebo response, a phenomenon equal but opposite to placebo… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Discovery of the involvement of endogenous opiates in placebo analgesia represents an important step in understanding the… (More)
Is this relevant?
Highly Cited
1995
1988
1988
The effects of gastrin, proglumide (a gastrin receptor antagonist), and somatostatin on growth of human colon adenocarcinoma cell… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
The onset, course, and regression of the biochemical and structural alterations associated with pancreatitis induced by various… (More)
Is this relevant?
1985
1985
Recent evidence has suggested that cholecystokinin (CCK) may act as a physiological opiate antagonist. Both the overlap of CCK… (More)
Is this relevant?
1985
1985
Some tumors are responsive to hormone manipulation. Some gastric and colonic adenocarcinomas from both humans and animals have… (More)
Is this relevant?
1984
1984
Exogenous cholecystokinin selectively antagonizes opiate analgesia, which suggests that endogenous cholecystokinin may act… (More)
Is this relevant?
1984
1984
Proglumide, a glutaramic acid derivative, inhibits the acid secretory effects of gastrin and is said to be a specific gastrin… (More)
Is this relevant?